Vivo Capital Viii, Llc's Net Worth
Vivo Capital Viii, Llc's net worth is estimated to be at least $25,728,645.27 as of 12/23/2024. CoreStreet's estimation of Vivo Capital Viii, Llc's net worth is based on their sale of stock and current holding of stock.
Vivo Capital Viii, Llc is Major Shareholder at Impel Neuropharma Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 237,711 units of IMPL stock on 12/18/2023. Their biggest sale was on 04/03/2020 when they sold 300,000 units of Crinetics Pharmaceuticals Inc stock for $4,140,000.00. They typically trade 3 times per year.
Total value of insider buys:
- $15,699,100.86
Total value of insider sells:
- $10,029,544.41
Most recent insider trade:
- Dec. 18, 2023
Vivo Capital Viii, Llc's Insider Trading History
| Impel Neuropharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 18, 2023 | Major Shareholder | 237,711 | $0.11 | Sell | $26,148.21 |
Dec. 15, 2023 | Major Shareholder | 100,000 | $0.29 | Sell | $29,000.00 |
April 27, 2021 | Major Shareholder | 575,000 | $15.00 | Buy | $8,625,000.00 |
| Bolt Biotherapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 20, 2023 | Major Shareholder | 54,700 | $0.92 | Sell | $50,324.00 |
Nov. 16, 2023 | Major Shareholder | 15,000 | $0.96 | Sell | $14,400.00 |
| Crinetics Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 17, 2020 | Major Shareholder | 84,598 | $15.40 | Sell | $1,302,809.20 |
April 15, 2020 | Major Shareholder | 215,810 | $15.50 | Sell | $3,345,055.00 |
April 7, 2020 | Major Shareholder | 6,115 | $14.20 | Sell | $86,833.00 |
April 3, 2020 | Major Shareholder | 300,000 | $13.80 | Sell | $4,140,000.00 |
March 9, 2020 | Major Shareholder | 528 | $19.50 | Sell | $10,296.00 |
Feb. 10, 2020 | Major Shareholder | 7,555 | $21.40 | Sell | $161,677.00 |
Feb. 7, 2020 | Major Shareholder | 5,905 | $22.00 | Sell | $129,910.00 |
Feb. 4, 2020 | Major Shareholder | 13,460 | $22.80 | Sell | $306,888.00 |
Jan. 31, 2020 | Major Shareholder | 5,400 | $21.70 | Sell | $117,180.00 |
Jan. 29, 2020 | Major Shareholder | 13,920 | $22.20 | Sell | $309,024.00 |
July 20, 2018 | Major Shareholder | 353,180 | $18.62 | Buy | $6,576,211.60 |
| Nabriva Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 18, 2017 | Major Shareholder | 52,631 | $9.46 | Buy | $497,889.26 |